Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 20 of 20 publications.

Ronquest NA, Paret K, Lucas A, Ciepielewska M, Hagan M. Quantifying the value of introducing an oral drug delivery option for edaravone: a review of analyses evaluating the economic impact of oral versus intravenous formulations. Clinicoecon Outcomes Res. 2022 Jul 27;14:499-511. doi: 10.2147/CEOR.S359025

Mareque M, Montesinos P, Font P, Guinea JM, De La Fuente A, Soto J, Oyaguez I, Brockbank J, Iglesias T, Llinares J, Sierra J. Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with Cd-33 positive acute myeloid leukaemia in Spain. Clinicoecon Outcomes Res. 2021 Apr 22;2021(13):263-77. doi: 10.2147/CEOR.S302097

Mladsi D, Barnett C, Aggarwal K, Vredenburg M, Dieterich D, Kim R. Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Clinicoecon Outcomes Res. 2020 Sep 14;2020(12):515-26. doi: 10.2147/CEOR.S262772

Bassali J, Gould IG, Kaye JA, Mladsi D, Mehta J. US budget impact model for selinexor in relapsed or refractory multiple myeloma. Clinicoecon Outcomes Res. 2020 Jun 19;12:317-25. doi: 10.2147/CEOR.S251070

Chen L, Xiong Y, Yan C, Zhou W, Endo Y, Xue H, Hu Y, Hu L, Leng X, Liu J, Lin Z, Mi B, Liu G. LncRNA KCNQ1OT1 accelerates fracture healing via modulating miR-701-3p/FGFR3 axis. FASEB J. 2020 Apr;34(4):5208-22. doi: 10.1096/fj.201901864RR

Rajagopalan K, Candrilli SD, Ajmera M. Impact of antiepileptic drug-treatment burden on health-care-resource utilization and costs. Clinicoecon Outcomes Res. 2018 Oct 16;2018(10):619-27. doi: 10.2147/CEOR.S180913

Saande CJ, Reed CH, Coonts CA, Hahn KE, Rowling MJ, Schalinske KL. Vitamin D derived from dietary whole egg is more effective than supplemental vitamin D3 in maintaining vitamin D balance in type 2 diabetic rats. Poster presented at the Experimental Biology 2017 Meeting; April 2017. [abstract] FASEB J. 2018 Oct 3; 31(S1):436.1. doi: 10.1096/fasebj.31.1_supplement.436.1

Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC. Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK. Clinicoecon Outcomes Res. 2017 Oct 16;9:641-52. doi: 10.2147/CEOR.S135609

Mao N, Lesher B, Liu Q, Qin L, Chen Y, Gao X, Earnshaw SR, McDade CL, Claudie C. Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China. Clinicoecon Outcomes Res. 2016 Jun;8:275-85.

Saande CJ, Schalinske KL, Rowling MJ. Whole egg consumption attenuates vitamin D insufficiency in type 1 diabetic rats. Poster presented at the Experimental Biology 2016 Meeting; April 2016. [abstract] FASEB J. 2016 Apr 1; 30(S1):917.8. doi: 10.1096/fasebj.30.1_supplement.917.8

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C. Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions. Clinicoecon Outcomes Res. 2013 Jan 1;5:69-85.

Arab L, Jardack P, Anthony MS, Schoeller DA. Validity and feasibility of self administered multiple web-based 24 hour recalls: diet day. FASEB J. 2008.

Arab L, Anthony MS, McKenzie DC, Hartline HL, Prentice E. Web-based multimedia dietary assessment tool for nutritional research. FASEB J. 2002;16 (5 Pt 1):A383.

Mikkola TS, Anthony MS, Clarkson TB, St Clair RW. Cholesterol efflux potential of serum from atherogenic diet-fed cynomolgus monkeys after long-term tibolone treatment or traditional hormone replacement therapy. FASEB J. 2001;15(4):A248.

Cline JM, Anthony MS, Register TC, Borgerink H, Clarkson TB. Tibolone does not stimulate the endometrium or breast in cynomolgus monkeys. FASEB J. 2001;15(4):A594.

Shadoan MK, Rankin SE, Anthony MS, Clarkson TB, Wagner JD. Tibolone increases lean mass and bone mineral density in cynomolgus monkeys. FASEB J. 2001;15(4):A595.

Patel RI, Davis PJ, Orr RJ, Ferrari LR, Rimar S, Hannallah RS, Cohen IT, Colingo K, Donlon JV, Haberkern CM, McGowan FX, Prillaman BA, Parasuraman TV, Creed MR. Single-dose ondansetron prevents postoperative vomiting in pediatric outpatients. Anesth Analg. 1997 Sep;85(3):538-45. doi: 10.1097/00000539-199709000-00011

Anthony MS, Pan Y-L, Hughes C, Bullock B, Clarkson TB. Hybrid hamsters as a model for estrogen effects on brain biomarkers. FASEB J. 1997 Feb;11:A107.

Gratz I, Allen E, Afshar M, Joslyn AF, Buxbaum J, Prillaman B. The effects of the menstrual cycle on the incidence of postoperative nausea and vomiting (PONV) and efficacy of ondansetron. Anesth Analg. 1996 Sep;83(3):565-9. doi: 10.1097/00000539-199609000-00022

Brosnihan KB, Weddle D, Anthony MS, Heise CM, Ferrario CM. Chronic estrogen or estrogen and progestin replacement on the renin-angiotensin system in ovariectomized cynomolgus monkeys. FASEB J. 1995;9:A51.